Press Release: Lee's Pharm : Sorrento's License Partner, Lee's Pharmaceutical Announces NDA Filing Acceptance by NMPA for Anti-PD-L1 Antibody Socazolimab for Treatment of Recurrent or Metastatic Cervical Cancer
Socazolimab is an anti-PD-L1 antibody licensed from Sorrento for the Greater China Territory by Lee's Pharma. China National Medical Products Administration
Read full article »
CEO
Lee's Pharm is a Private company. Lee's Pharm generates $1M in revenue per employee Lee's Pharm has 2 followers on Owler.